BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Cumberland Pharmaceuticals to Announce 2011 Year End Financial Results on February 29, 2012

  February 8, 2012

   · 

  1 min read
• Business

  Myelin Repair Foundation and ENDECE Neural Form Collaboration to Develop Myelin Regenerative Compounds for Multiple Sclerosis (MS) Treatment

  February 8, 2012

   · 

  3 min read
• Prime Therapeutics President and CEO Eric Elliott Cites Urgent Need for “True Integration” of PBMs, Plans at 2012 PCMA Managed Markets Educational Forum

  February 8, 2012

   · 

  2 min read
• Business

  CIVCO Medical Solutions Announces Sales and Marketing Leadership Restructuring

  February 8, 2012

   · 

  2 min read
• Nervous GlaxoSmithKline Pulls Cash Out of Eurozone to Avoid Crisis

  February 8, 2012

   · 

  1 min read
• Business

  Sanofi (France) Profit Faces 15 Percent Hit from Cheap Drug Copies

  February 8, 2012

   · 

  1 min read
• Drug Development

  Novartis AG Reports Positive Data from Trial of Bexsero Vaccine for Meningitis

  February 8, 2012

   · 

  11 min read
• Drug Development

  Merck & Co., Inc. Rotavirus Vaccine Not Linked to Bowel Problems in Study

  February 8, 2012

   · 

  1 min read
• Business

  Mayo Clinic Spin-out Tenex Health Lands $11.8 Million

  February 8, 2012

   · 

  1 min read
• Business

  Velomedix, Inc. Closes $10.2 Million in Series B Funds, Adds CEO and VP

  February 8, 2012

   · 

  3 min read